https://www.selleckchem.com/pr....oducts/sndx-5613.htm
Follow-up assessment confirmed clinical remission in initial responders (with FL values reduced on the average by 94 ± 10% compared to baseline). In CD and UC patients during induction with biologic agents, early FL measurements accurately separate clinical responders from those experiencing PNR. The method described here offers several potential advantages over other strategies to assess and manage these patients. In CD and UC patients during induction with biologic agents, early FL measurements accurately separate clinical responder
Like
Comment
Share
